20 May 2013
Keywords: fda, panel, backs, abbott, xience, stent, circulatory
Article | 10 December 2007
The Circulatory System Devices Advisory Panel to the US Food and Drug Administration has recommended approval for Abbott Laboratories' Xience
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
10 December 2007
17 December 2007
17 May 2013
© 2013 thepharmaletter.com